113 related articles for article (PubMed ID: 27579736)
21. Immunohistochemical detection of Bcl-2 in Kaposi's sarcoma lesions varies according to histopathologic stage, whereas expression of Bcl-x and Mcl-1 differs according to human immunodeficiency virus serologic status of patients.
Fernández-Figueras MT; Puig L; Fernández-Vasalo A; Esquius M; Montero MA; Ariza A
Mod Pathol; 2000 Apr; 13(4):438-45. PubMed ID: 10786812
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma: clinical and pathological aspects in patients seen at the Hospital Universitário Cassiano Antônio Moraes - Vitória - Espírito Santo - Brazil.
Tiussi RM; Caus AL; Diniz LM; Lucas EA
An Bras Dermatol; 2012; 87(2):220-7. PubMed ID: 22570025
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic Kaposi's sarcoma: a study of eight patients.
Tourlaki A; Recalcati S; Boneschi V; Gaiani F; Colombo A; Mancuso R; Brambilla L
Eur J Dermatol; 2013; 23(3):382-6. PubMed ID: 23783037
[TBL] [Abstract][Full Text] [Related]
24. Absence of Fas (CD95) and FasL (CD95L) immunohistochemical expression suggests Fas/FasL-mediated apoptotic signal is not relevant in cutaneous Kaposi's sarcoma lesions.
Fernández-Figueras MT; Armengol P; Puig L; Molinero JL; Esquius M; Sirera G; Ariza A
J Cutan Pathol; 1999 Oct; 26(9):417-23. PubMed ID: 10563496
[TBL] [Abstract][Full Text] [Related]
25. [Kaposi's sarcoma: epidemiological, clinical, anatomopathological and therapeutic features in 75 patients].
Zaraa I; Labbene I; El Guellali N; Ben Alaya N; Mokni M; Ben Osman A
Tunis Med; 2012 Feb; 90(2):116-21. PubMed ID: 22407622
[TBL] [Abstract][Full Text] [Related]
26. Expression of the fibroblast/macrophage marker 1B10 by spindle cells in Kaposi's sarcoma lesions and by Kaposi's sarcoma-derived tumor cells.
Simonart T; Degraef C; Heenen M; Hermans P; Van Vooren JP; Noel JC
J Cutan Pathol; 2002 Feb; 29(2):72-8. PubMed ID: 12150136
[TBL] [Abstract][Full Text] [Related]
27. An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma.
Bergman R; Ramon M; Kilim S; Lichtig C; Friedman-Birnbaum R
Am J Dermatopathol; 1996 Aug; 18(4):367-70. PubMed ID: 8879300
[TBL] [Abstract][Full Text] [Related]
28. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
29. A fifth subtype of Kaposi's sarcoma, classic Kaposi's sarcoma in men who have sex with men: a cohort study in Paris.
Denis D; Seta V; Regnier-Rosencher E; Kramkimel N; Chanal J; Avril MF; Dupin N
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1377-1384. PubMed ID: 29377280
[TBL] [Abstract][Full Text] [Related]
30. Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumors.
Ferrari L; Della Torre S; Collini P; Martinetti A; Procopio G; De Dosso S; Bajetta R; Catena L
Tumori; 2006; 92(6):531-5. PubMed ID: 17260495
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
33. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
34. Classic and iatrogenic Kaposi's sarcoma. Histopathological patterns as related to clinical course.
Friedman-Birnbaum R; Bergman R; Bitterman-Deutsch O; Weltfriend S; Lichtig C
Am J Dermatopathol; 1993 Dec; 15(6):523-7. PubMed ID: 8311180
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.
Moses AV; Jarvis MA; Raggo C; Bell YC; Ruhl R; Luukkonen BG; Griffith DJ; Wait CL; Druker BJ; Heinrich MC; Nelson JA; Früh K
J Virol; 2002 Aug; 76(16):8383-99. PubMed ID: 12134042
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of Kaposi's sarcoma.
Blumenfeld W; Egbert BM; Sagebiel RW
Arch Pathol Lab Med; 1985 Feb; 109(2):123-7. PubMed ID: 2983633
[TBL] [Abstract][Full Text] [Related]
37. HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry.
Pak F; Pyakural P; Kokhaei P; Kaaya E; Pourfathollah AA; Selivanova G; Biberfeld P
J Cutan Pathol; 2005 Jan; 32(1):21-7. PubMed ID: 15660651
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry in Kaposi's sarcoma.
Pantanowitz L; Otis CN; Dezube BJ
Clin Exp Dermatol; 2010 Jan; 35(1):68-72. PubMed ID: 19874352
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma: a population-based cancer registry descriptive study of 57 consecutive cases diagnosed between 1977 and 2009.
Laresche C; Fournier E; Dupond AS; Woronoff AS; Drobacheff-Thiebaut C; Humbert P; Aubin F
Int J Dermatol; 2014 Dec; 53(12):e549-54. PubMed ID: 24962354
[TBL] [Abstract][Full Text] [Related]
40. Intravascular Kaposi's sarcoma - a hitherto unrecognized phenomenon.
Luzar B; Antony F; Ramdial PK; Calonje E
J Cutan Pathol; 2007 Nov; 34(11):861-4. PubMed ID: 17944727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
